Literature DB >> 18037016

Models of PTSD and traumatic stress: the importance of research "from bedside to bench to bedside".

Robert J Ursano1, He Li, Lei Zhang, Chris J Hough, Carol S Fullerton, David M Benedek, Thomas A Grieger, Harry C Holloway.   

Abstract

The epidemiology and psychology of PTSD noted above is not often considered in neurobiological models of PTSD. Neurobiological models tend to focus on symptoms. This is an important perspective but it does not capture the brains total response to traumatic events. Similarly, neurobiologists have rarely used the extensive knowledge of animal behavioral responses to stress as a means to define the human stress phenomenology, looking for the human equivalent (rather than the other way around). The development of animal models for PTSD and other traumatic stress-related brain changes is an important part of advancing our neurobiological understanding of the disease process as well as recovery, resilience, and possible therapeutic targets. Animal models should address symptoms but also other aspects of PTSD that are seen in clinical care including the waxing and waning of symptoms, Understanding "forgetting", toxic exposure, failure to recover and how the neural systems fail rather than function are important perspectives on developing animal models. The cognitive process of identification is another important animal model to develop. Using these perspectives recent work has shown new avenues for understanding the trauma response in animal models and human brain tissue of individuals with PTSD. The 5-HT2A receptor and p11 protein and associated regulators are avenues of new investigation that warrant study and consideration in models of PTSD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18037016     DOI: 10.1016/S0079-6123(07)67014-9

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  6 in total

1.  Preclinical perspectives on posttraumatic stress disorder criteria in DSM-5.

Authors:  Susannah Tye; Elizabeth Van Voorhees; Chunling Hu; Timothy Lineberry
Journal:  Harv Rev Psychiatry       Date:  2015 Jan-Feb       Impact factor: 3.732

2.  The relevance of epigenetics to PTSD: implications for the DSM-V.

Authors:  Rachel Yehuda; Linda M Bierer
Journal:  J Trauma Stress       Date:  2009-10-07

3.  Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.

Authors:  Akshayan Vimalanathan; Darryl C Gidyk; Mustansir Diwan; Flavia V Gouveia; Nir Lipsman; Peter Giacobbe; José N Nobrega; Clement Hamani
Journal:  Neuropharmacology       Date:  2020-01-13       Impact factor: 5.250

Review 4.  Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience.

Authors:  John H Krystal; Alexander Neumeister
Journal:  Brain Res       Date:  2009-03-28       Impact factor: 3.252

Review 5.  Eyeblink classical conditioning and post-traumatic stress disorder - a model systems approach.

Authors:  Bernard G Schreurs; Lauren B Burhans
Journal:  Front Psychiatry       Date:  2015-04-08       Impact factor: 4.157

Review 6.  Epigenetic Approach to PTSD: In the Aspects of Rat Models.

Authors:  Asli Aykac; Rasime Kalkan
Journal:  Glob Med Genet       Date:  2021-11-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.